OR11Q1P

Across TCGA pan-cancer cohorts, OR11Q1P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR11Q1P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR11Q1P RNA is repressed in tumor relative to normal tissue. In most cancer types OR11Q1P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA, LIHC, and THCA are the cancer types where OR11Q1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR11Q1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	−0.366	<.001	6	view →
LIHC	All	All	+0.423	.003	5	view →
THCA	All	All	+0.033	.007	4	view →
CHOL	All	All	+0.616	.014	2	view →
LUSC	All	All	+0.051	.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OR11Q1P–BRCA

Open the BRCA breakdown →